Consequently, beyond its established utility in risk stratification and prognostic assessment of overt CVD such as heart failure (5–7), NT-proBNP may also serve as an indicator of subclinical cardiac stress or early myocardial dysfunction, particularly in individuals without a history of CVD, thereby providing crucial information for early diagnosis (8, 9). The gene discussed is NPPB; the disease is heart failure.